Dr. Kamil Reza Khondakar is a senior assistant Professor at Woxsen University, Hyderabad, India. He earned his Ph.D. from the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland, Australia, where his research centered on developing microfluidic assays for detecting cancer biomarkers. He has edited 3 books and authored over 50 international research publications in the fields of lab-on-a-chip technology, electrochemical sensors, optical sensors, and machine learning assisted sensors for the advancement of personalized healthcare systems. He is also serving editorial roles for journal Frontiers in nanotechnology and Sensors (MDPI). He was awarded the Startup Research Grant (SRG-2023) by the Science & Engineering Research Board (SERB), Government of India, to develop microfluidic chip-based sensors for detecting water contamination. He also received International Postgraduate Research Scholarship (IPRS) from Government of Australia, and University of Queensland Centennial Scholarship (UQCent) from The University of Queensland, Australia. He was invited speaker at international conferences in USA, Australia and India. He has been affiliate member of the Royal Society of Chemistry since 2024 (invited). Dr. Ajeet Kaushik is Associate Professor at the NanoBioTech Laboratory, Department of Environmental Engineering, Florida Polytechnic University, USA. He is the recipient of various reputed awards for his service in the area of nano-biotechnology for health care. He has edited seven books, written more than 100 international research peer reviewed publications, and has three patents in the area of nanomedicine and smart biosensors for personalized health care. In the course of his research, Dr. Kaushik has been engaged in the design and development of various electro-active nanostructures for electrochemical biosensor and nanomedicine for health care. His research interests include nanobiotechnology, analytical systems, design and develop nanostructures, nano-carries for drug delivery, nano-therapeutics for CNS diseases, on-demand site-specific release of therapeutic agents, exploring personalized nanomedicines, biosensors, point-of-care sensing devices, and related areas of health care monitoring.